Cargando…
SMYD3: a regulator of epigenetic and signaling pathways in cancer
Chromatin modifiers and their implications in oncogenesis have been an exciting area of cancer research. These are enzymes that modify chromatin via post-translational modifications such as methylation, acetylation, sumoylation, phosphorylation, in addition to others. Depending on the modification,...
Autores principales: | Bernard, Benjamin J., Nigam, Nupur, Burkitt, Kyunghee, Saloura, Vassiliki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912509/ https://www.ncbi.nlm.nih.gov/pubmed/33637115 http://dx.doi.org/10.1186/s13148-021-01021-9 |
Ejemplares similares
-
Clinicopathologic significance of protein lysine methyltransferases in cancer
por: Vougiouklakis, Theodore, et al.
Publicado: (2020) -
Epigenetic Modifiers as Novel Therapeutic Targets and a Systematic Review of Clinical Studies Investigating Epigenetic Inhibitors in Head and Neck Cancer
por: Burkitt, Kyunghee, et al.
Publicado: (2021) -
SMYD3: An Oncogenic Driver Targeting Epigenetic Regulation and Signaling Pathways
por: Bottino, Cinzia, et al.
Publicado: (2020) -
WHSC1 monomethylates histone H1 and induces stem-cell like features in squamous cell carcinoma of the head and neck
por: Saloura, Vassiliki, et al.
Publicado: (2020) -
SMYD3 represses tumor-intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neck
por: Nigam, Nupur, et al.
Publicado: (2023)